logo-loader
Futura Medical PLC

Futura Medical on the rise as Liberum says newspaper article could spark interest in group’s main ED product

Over the weekend The Guardian published an in-depth piece on the emerging treatments for erectile dysfunction (ED) with a significant focus on Futura's MED2005 product

Couple in bed
“This will help to drive interest in what appears to be a very over-looked product in terms of its potential to address a very large market," Liberum's analysts said

Futura Medical PLC (LON:FUM) saw its shares shoot higher on Monday after ‘house’ broker Liberum Capital highlighted an article published in ‘The Guardian’ newspaper which could spark interest in the group’s main product.

In a note to clients, the City broker’s analysts pointed out that over the weekend the newspaper published an in-depth piece on the emerging treatments for erectile dysfunction (ED) with a significant focus on the AIM-listed firm’s MED2005 which is in a P3 study due to read-out by the end of the year.

READ: Futura Medical trial on track to deliver “major value inflection point”

They said: “The article highlights the lack of clinical advances in ED over the past 20 years and the emerging opportunity for products that can address the shortcomings of the PDe-5 inhibitor class (Viagra) with MED2005 appearing to offer convenience and side-effect profile benefits.”

The analysts concluded: “This will help to drive interest in what appears to be a very over-looked product in terms of its potential to address a very large market.”

In afternoon trading, shares in Futura Medical were up 11.6% at 23.15p.

Quick facts: Futura Medical PLC

Price: £0.32

Market: AIM
Market Cap: £65.49 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical's James Barder looking forward to headline data on lead drug...

Futura Medical PLC (LON:FUM) chief executive James Barder caught up with Proactive London's Andrew Scott to talk through the firm's interim results. He says the company’s team is speaking to key opinion leaders in the field of erectile dysfunction ahead of publishing headline data on lead...

1 week, 1 day ago

2 min read

;